Perspectives on the bioenergetic dysregulation in insulin-resistant patients comorbid with cancer
World Journal of Translational Medicine · 2026
DOI: 10.5528/wjtm.124147 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Translational Medicine, 2026. Verfasst von Dina Johar und 2 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Insulin resistance, a pathophysiological response in metabolic syndrome, raises cancer risk. Mitochondrial dysfunction is a hallmark of cancer. The mitochondrial energetic profile of platelets in patients with cancer who have insulin resistance is unclear. Similarly, the profile of mitochondrial dysfunction in type 2 diabetes (T2-D) has not yet been published. The transmembrane protein in human adipose tissue known as dipeptidyl peptidase 4 (DPP4) is associated with T2-D secondary to obesity. Furthermore, DPP4 has been implicated in cancer pathogenesis. Studies have shown a connection between obesity and cancer. However, whether DPP4 inhibition ameliorates insulin resistance in patients with cancer has not been elucidated. This perspective aims to explore how platelet mitochondria fail in patients with cancer who have insulin resistance, discuss how blocking DPP4 might antagonize insulin resistance in cancer, and describe a cell culture model for obesity and insulin resistance. The available literature supports the proposal that patients with cancer and insulin resistance (or T2-D) have less active mitochondria in their platelets than patients with cancer without insulin resistance or healthy individuals. The platelet mitochondrial bioenergetic profile may signal early mitochondrial dysfunction in patients with cancer and insulin resistance. The proposed model is applicable to patients with T2-D and obesity.
Zitieren
APA
Johar, D., Mahmoud, K., & Zaky, S. (2026). Perspectives on the bioenergetic dysregulation in insulin-resistant patients comorbid with cancer. World Journal of Translational Medicine. https://doi.org/10.5528/wjtm.124147
Vancouver
Johar D, Mahmoud K, Zaky S. Perspectives on the bioenergetic dysregulation in insulin-resistant patients comorbid with cancer. World Journal of Translational Medicine. 2026. doi:10.5528/wjtm.124147
BibTeX
@article{Johar2026,
author = {Johar, Dina and Mahmoud, Khaled and Zaky, Samy},
title = {Perspectives on the bioenergetic dysregulation in insulin-resistant patients comorbid with cancer},
journal = {World Journal of Translational Medicine},
year = {2026},
doi = {10.5528/wjtm.124147}
}
EUVIMED